Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients

Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brendan A. Daisley, Ryan M. Chanyi, Kamilah Abdur-Rashid, Kait F. Al, Shaeley Gibbons, John A. Chmiel, Hannah Wilcox, Gregor Reid, Amanda Anderson, Malcolm Dewar, Shiva M. Nair, Joseph Chin, Jeremy P. Burton
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/d057b42a310240ed8e3bbeaf06f35107
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d057b42a310240ed8e3bbeaf06f35107
record_format dspace
spelling oai:doaj.org-article:d057b42a310240ed8e3bbeaf06f351072021-12-02T18:14:16ZAbiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients10.1038/s41467-020-18649-52041-1723https://doaj.org/article/d057b42a310240ed8e3bbeaf06f351072020-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18649-5https://doaj.org/toc/2041-1723Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muciniphila at the expense of androgen-utilizing Corynebacterium species.Brendan A. DaisleyRyan M. ChanyiKamilah Abdur-RashidKait F. AlShaeley GibbonsJohn A. ChmielHannah WilcoxGregor ReidAmanda AndersonMalcolm DewarShiva M. NairJoseph ChinJeremy P. BurtonNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Brendan A. Daisley
Ryan M. Chanyi
Kamilah Abdur-Rashid
Kait F. Al
Shaeley Gibbons
John A. Chmiel
Hannah Wilcox
Gregor Reid
Amanda Anderson
Malcolm Dewar
Shiva M. Nair
Joseph Chin
Jeremy P. Burton
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
description Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muciniphila at the expense of androgen-utilizing Corynebacterium species.
format article
author Brendan A. Daisley
Ryan M. Chanyi
Kamilah Abdur-Rashid
Kait F. Al
Shaeley Gibbons
John A. Chmiel
Hannah Wilcox
Gregor Reid
Amanda Anderson
Malcolm Dewar
Shiva M. Nair
Joseph Chin
Jeremy P. Burton
author_facet Brendan A. Daisley
Ryan M. Chanyi
Kamilah Abdur-Rashid
Kait F. Al
Shaeley Gibbons
John A. Chmiel
Hannah Wilcox
Gregor Reid
Amanda Anderson
Malcolm Dewar
Shiva M. Nair
Joseph Chin
Jeremy P. Burton
author_sort Brendan A. Daisley
title Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
title_short Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
title_full Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
title_fullStr Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
title_full_unstemmed Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
title_sort abiraterone acetate preferentially enriches for the gut commensal akkermansia muciniphila in castrate-resistant prostate cancer patients
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/d057b42a310240ed8e3bbeaf06f35107
work_keys_str_mv AT brendanadaisley abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT ryanmchanyi abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT kamilahabdurrashid abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT kaitfal abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT shaeleygibbons abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT johnachmiel abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT hannahwilcox abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT gregorreid abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT amandaanderson abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT malcolmdewar abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT shivamnair abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT josephchin abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
AT jeremypburton abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients
_version_ 1718378422549348352